Team / Founders:1. Dr. Aridni Shah,  2.Trisha Chatterjee,
What startup does?:immunitoAI’s full-stack platform predicts the best therapeutic antibody candidates, saving time by 60 percent and money by 50 percent, and doubling the efficiency. Their first product named imRANK is an AI which screens and ranks existing antibody sequences to predict the best binding strength with a given antigen of one’s choice. imRANK is in the R&D phase, the beta version will be available soon. Their second product named imEVOLVE is an AI which identifies and mutates regions of antibodies that aids in higher binding affinity with the antigen of one’s choice.
Year of Incorporation:2020
Share this post on social media